Broadview Ventures
Overview
Broadview Ventures is a mission-driven investment organization that makes targeted investments in early-stage companies to accelerate the development of innovative therapeutics, devices, and diagnostics for cardiovascular disease and stroke. The firm invests in companies across North America, Europe, and Israel.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alleviant Medical | Jan 2025 | VC Round | Co-investor |
| AtaCor Medical | Oct 2025 | Financing | Co-investor |
| Aria CV | Jul 2015 | Series A | Co-investor |
| Nyra Medical | Nov 2022 | Series A | Co-investor |
| Kantum Pharma | Jul 2021 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Kelly Krajnik
Director, Head of Medtech
Benjamin Kreitman
Principal
David Prim
Principal
Hewmun Lau
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Broadview Ventures based?
Broadview Ventures is headquartered in Boston, Massachusetts, United States.
When was Broadview Ventures founded?
Broadview Ventures was founded in 2009.
How many portfolio companies does Broadview Ventures have?
Broadview Ventures has 26 portfolio companies in Caplight's dataset.
What are some companies in Broadview Ventures's portfolio?
Portfolio companies visible on Caplight include Alleviant Medical, AtaCor Medical, Aria CV, Nyra Medical, Kantum Pharma.
What was Broadview Ventures's most recent investment shown here?
Broadview Ventures's most recent investment in this portfolio sample was in AtaCor Medical in 2025.
What sectors does Broadview Ventures focus on?
Broadview Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Broadview Ventures focus on?
Broadview Ventures typically invests at the Early stage.
What is Broadview Ventures's AUM?
Broadview Ventures's assets under management are estimated between $100.0M and $250.0M.